5-arylpyrimidines as anticancer agents

Details for Australian Patent Application No. 2004275733 (hide)

Owner Wyeth Holdings Corporation

Inventors Zhang, Nan; Ayral-Kaloustian, Semiramis; Nguyen, Thai Hiep

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004275733

PCT Pub. Number WO2005/030216

Priority 60/505,487 24.09.03 US

Filing date 17 September 2004

Wipo publication date 7 April 2005

International Classifications

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/48 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/030216 Priority application(s): WO2005/030216

3 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004275735-A method and apparatus for flexible fixation of a spine

2004275728-6-aryl-7-halo-imidazo[1,2-a]pyrimidines as anticancer agent